|
Volumn 19, Issue 6, 2013, Pages 655-
|
Basket studies will hold intricate data for cancer drug approvals
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
B RAF KINASE;
BRAF PROTEIN, HUMAN;
INDOLE DERIVATIVE;
SULFONAMIDE;
VEMURAFENIB;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
GENETICS;
HUMAN;
METHODOLOGY;
MUTATION;
NEOPLASM;
NOTE;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
HUMANS;
INDOLES;
MUTATION;
NEOPLASMS;
PROTO-ONCOGENE PROTEINS B-RAF;
RESEARCH DESIGN;
SULFONAMIDES;
|
EID: 84880991913
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0613-655 Document Type: Article |
Times cited : (60)
|
References (0)
|